Literature DB >> 7229966

Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.

A El-Yazigi, R J Sawchuk.   

Abstract

Theophylline pharmacokinetics following oral and intravenous administration were studied, and the absolute bioavailability of five commercially available products was determined using the rabbit as an in vivo model. Concentration-dependent clearance studies were performed by multiple constant-rate infusion and multiple bolus dose administration of aminophylline. Theophylline pharmacokinetics following the oral administration of these products obeyed the one-compartment open model adequately. However, the data obtained following rapid intravenous aminophylline administration in the rabbit fit either the one-compartment model (half-life = 2.8 hr and the volume of distribution = 4.4 hr and Vd(beta) = 0.708 liter/kg). There were no significant product-to-product differences in the time to peak (tmax), the rate constant of absorption (ka), or the percent of dose absorbed at 1 hr (F1); however, differences in the absolute bioavailability (F), dose-normalized peak serum concentration (Cmax(n)), and percent of dose absorbed at 6 hr (F6) were significant. There was no evidence of concentration-dependent clearance for theophylline in the rabbit in the serum concentration range studied, but the results of the multiple constant-rate infusion study suggest that total clearance decreases at higher serum theophylline concentrations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229966     DOI: 10.1002/jps.2600700429

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Bioavailability of oral isbufylline in rabbits.

Authors:  A Celardo; G Dell'Elba; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

2.  Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies.

Authors:  A El-Yazigi; C R Martin
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

3.  Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.

Authors:  Panteleimon D Mavroudis; Helen E Hermes; Donato Teutonico; Thomas G Preuss; Sebastian Schneckener
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.